O GoConqr está de visual novo! Conte para nós o que você achou.

Flashcards

SU5505 Midterm Test

Annie Nguyen Inglês 41 flashcards

SU5505 Midterm Test

Flashcards do conjunto (41)

  1. 1List the 7 steps for Spirometry interpretation1. Six seconds long
    2. Flow volume loop shape
    3. FEV1/ FVC >70%
    4. FVC > 80%
    5. FEV1 > 80%
    6. ID pattern
    7. Classify Severity
  2. 2—LV hypertrophy: Increased R wave peak time:Left ventricular strain pattern:
    *T wave inversion in the lateral leads V5-6*
    LV hypertrophy: Increased R wave peak time:Left ventricular strain pattern: *T wave inversion in the lateral leads V5-6*
  3. 3Proventil HFA, ProAir, Xopenex is an example of ?SABA: Short- acting beta agonist ( short-acting bronchodilator)
  4. 4Aerospan, Flovent, Pulmicort and Qvar are examples of ?ICS- inhaled corticosteriods
  5. 5Foradil and Serevent are examples of ?LABA
  6. 6Atrovent, Combivent, Tudorza, and Spiriva are examples of ????Anticholinergics
  7. 7Advair, Breo, Dulera, and Symbicort are examples of?????Combo Medications: ICS and LABA
  8. 8Gold Standard DX for COPDSpirometry
  9. 9Diagnostics for Asthma20% variation in PEF (liters/mins)
    Spirometry
  10. 10Peak Flow Measurement 1. Stand___ 2. Cursor at _____ 3. Blow _____& _____ 4. Best of _____ attempts 5. Record _______ best.1. Stand up
    2. Cursor at zero
    3. Blow hard & fast
    4. Best of 3 attempts
    5. Record personal best.
  11. 11Deaths from Asthma is best reduced by.... 1. written _______ plan 2. Oral _______ prior to severe attack 3. Use of Peak _____ meter ( Liters/mins.)1. written Action plan
    2. Oral corticosteroids prior to severe attack
    3. Use of Peak Flow meter ( Liters/mins.)
  12. 12This type of Asthma Medication benefits those who are obese, smoke, or triad of asthmaLeukotriene medications: SingulairThis type of Asthma Medication benefits those who are obese, smoke, or triad of asthma
  13. 13Triad Asthma criteriaNasal polyps
    ASA sensitivity
    Severe asthma
  14. 14Asthma Control Test A score of ____ is controlled asthmatic.<19 not controlled
    >20 is well controlled
  15. 15What medication increase the risk of pneumonia in COPD patients?Corticosteroid do not cause Pneumonia or osteoporosis in asthmatics, however those with COPD .
  16. 16Peak Flow Monitoring 1. best lung function __ pm & lowest __am 2. ___% fluctuation is healthy 3. ___% variation DX of asthma 4. NOT USED FOR _____.1. best lung function 4 pm & lowest 4am
    2. 8% fluctuation is healthy
    3. 20% variation DX of asthma
    4. NOT USED FOR COPD.
    * effort dependent*
  17. 17Schedule of Asthma Follow up 1st F/U within ____ month. Routine visit ___ to ___ months.1st F/U within 1 month.
    Routine visit 1 to 6 months.
    *assess correct use of inhaler, spacer, peak flow meter (PFM)*
  18. 18COPD is not fully ________.COPD is not fully reversible.
    Preventable and treatable.
  19. 19Productive cough for 3 consecutive months for 2 consecutive years.Chronic Bronchitis
  20. 20COPD SOB manifest at __ % of lung functionSOB manifest at 50 % of lung function
  21. 21PATHO of COPD 1. increases in ______ and neutrophils. 2. ______ hyperplasia. 3. Bronchiolar ______. 4. Peribronchiolar ________. 5. Loss of _______ attachments.1. increases in macrophages and neutrophils.
    2. bronchiolar hyperplasia.
    3. Bronchiolar edema.
    4. Peribronchiolar fibrosis.
    5. Loss of alveolar attachments.
  22. 22COPD presentation 1. SXS present at 1 PPD for > ____ years. 2. manifestation at _____ decade: chronic cough after viral infx. 3. Dypsnea at ___ or ____ decade.1. SXS present at 1 PPD for > 20 years.
    2. manifestation at fifth decade: chronic cough after viral infx.
    3. Dypsnea at sixth or seventh decade.
  23. 23COPD Physical Exam 1. ______ and _____ expiration. 2. Chest wall _______inflation. 3. Distant _____ and ____ sounds. 4. Pursed ____ breathing. 5. Cor ______: JVD, edema, heptomegaly1. Slow and prolonged expiration.
    2. Chest wall hyperinflation.
    3. Distant heart and breath sounds.
    4. Pursed lip breathing.
    5. Cor pulmonale: JVD, edema, heptomegaly
  24. 24COPD Chest XrayCOPD Chest XRAY
    1. flat diaphragm
    2. tear shaped heart
    3. Increase AP/ retrosternal airspace
    *Emphysema: pruning of pulmonary vessels and bullae*
    COPD Chest Xray
  25. 25COPD assessment test (CAT) < 10 > 10Group A: low risk, less SXS (CAT< 10)
    Group B: low risk, more SXS (CAT>10)
    Group C: high risk, less SXS (CAT< 10)
    Group D: high risk, high SXS (CAT >10)
    *GROUP B &D: 5x risk for cardiovascular dx and cancer*
  26. 26COPD Treatment : 1st Choice Group A and BGroup A: SAAC (Atrovent/ combivent) or
    SABA (Proair, Proventil)
    Group B: LAAC (spiriva/anora ) or LABA (Foradil/ Serevent)
    * add- on exercise and pulmonary rehab*
  27. 27COPD 1st choice treatment for Group C and DGroup C: LAAC (Anora/Spriva) and (+)LABA ( Foradil/Serevent)
    Group D: ICS (Flovent/ Pulmicort) and(+)LABA or LAAC
    * add- on exercise, oxygen therapy pulmonary rehab*
  28. 28Spirometry List the predicted values/ criteria.1. Gender
    2. Race
    3. Age
    4. height
  29. 29____ _____ _____ (FVC) maximum volume of air exhaled _____ _____ ______ (FEV1): volume exhaled during the first second.Forced Vital Capacity: maximum volume of air exhaled
    Forced Expiratory Volume: volume exhaled during the first second.
  30. 30Normal Lung Volume Values FEV / FVC1 >____% FVC > _____% FEV1 > _____%Normal Lung Volume Values
    FEV / FVC1 >70%
    FVC > 80 %
    FEV1 > 80 %
  31. 31Obstructive vs Restrictive Disease pattern Obstructive: FEV1 / FVC _____, FVC _____ FEV1_____Obstructive: FEV1 / FVC down , FVC normal, FEV1 down
  32. 32Obstructive vs Restrictive Disease pattern Restrictive : FEV1 / FVC _____, FVC _____ FEV1_____Restrictive : FEV1 / FVC normal , FVC down FEV1 down
    Combined:FEV1 / FVC down, FVC down, FEV1 down
  33. 33Obstructive Lung DiseasesAsthma
    COPD
    Bronchiectasis
    Cystic Fibrosis
  34. 34Obstructive Reversibility defined as a change of ____% post Albuterol (SABA) or Ipratropium (Atrovent) and increase of _______ mL.Obstructive Reversibility
    defined as a change of 12 % post Albuterol (SABA) or Ipratropium (Atrovent) and increase of 200 mL.
  35. 35CAD inflammation marker. < 1 low risk for CV events 1-3 intermediate >3 highHigh Sensitivity CRP (hs-CRP)
  36. 36Which is an independent risk factor for CHD? HDL, LDL, TriglyceridesElevated Triglycerides are an independent risk factor for CHD. Low HDL independent predictor
    (inverse relationship)
    Normal < 150
    Borderline 150-199
    High > 200- increased risk for pancreatitis
  37. 37What are the criteria for Metabolic syndrome? Metabolic syndrome- 3+SXS to DX1. Abdominal obesity (M >40in. W> 35)
    2. Triglyceride> 150 mg/dl
    3. Low HDL ( M<40, W< 50)
    4. High BP ( 130/85)
    5. Fast blood glucose (> 110)
  38. 38DXD for Dyslipidemia1. DM
    2. Hypothyroidism
    3. obstructive liver dx
    4. Chronic renal failure
    5. Protease inhibitor ( HIV meds)
    6. BBB, HCTZ= low HDL
    7. Prednisone ( high TG)
    8. Tamoxifen- high TG ( Breast CA)
  39. 39—Non occlusive thrombus
    unstable angina and non-Q wave MI
    Non occlusive thrombus unstable angina and non-Q wave MI
  40. 40—Occlusive thrombus
    Q wave MI and sudden death
    Occlusive thrombus Q wave MI and sudden death
  41. 41—

Informações

Descrição
ANP: LUNG and Heart
Criado por
Annie Nguyen
Visualizações
79
Avaliação

Fale Conosco

Sobre o que é sua mensagem?

O que você acha do novo visual?

Você gostou?